Showing results (1031-1040 of 5,056) with videos related to

Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|May 21, 2025
Multiple sclerosis relapse incomplete recovery and associated factors - a systematic review and meta-analysisFilipa Ladeira, Mafalda Soares, Patrícia Faustino, et al.
Multiple Sclerosis and Related Disorders|July 12, 2025
Heterogeneity in health care pathways preceding the classical recognition of adult-onset multiple sclerosis: A multichannel state sequence analysisFardowsa L A Yusuf, Mohammad Ehsanul Karim, Jason M Sutherland, et al.
Multiple Sclerosis and Related Disorders|July 15, 2025
Prevalence and distribution of HPV genotypes in female patients with multiple sclerosisMojtaba Shahbazi, Maryam Kaeedi, Sanaz Heydari Havadaragh, et al.
Multiple Sclerosis and Related Disorders|July 25, 2025
Significant upregulation of prenyltransferase-related genes in neuromyelitis optica: Diagnostic potential and clinical correlationsMohammad Taheri, Fatemeh Sadat Feghahati, Bashdar Mahmud Hussen, et al.
Multiple Sclerosis and Related Disorders|July 18, 2025
"I see diet almost as another disease modifying therapy. It's that important." A qualitative study of dietitian and nursing perspectives on the role of diet and brain health for multiple sclerosisEmma Ware-Maloney, Olivia Wills, Yasmine Probst
Multiple Sclerosis and Related Disorders|July 25, 2025
Multiple sclerosis and sarcopenia: analysis of population-level prevalence and key risk factors from the UK BiobankMatti D Allen, Anthony Thompson, Brian C Clark, et al.
Multiple Sclerosis and Related Disorders|July 23, 2025
Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trialLudwig Kappos, Michel Burcklen, Daniele D'Ambrosio, et al.
Multiple Sclerosis and Related Disorders|July 30, 2025
A single nucleotide polymorphism in the MerTK gene is associated with increased radiological disease activity in patients with multiple sclerosis on natalizumab therapyMelissa Minhui Chu, Vivien Li, Tomas Kalincik, et al.
Multiple Sclerosis and Related Disorders|August 2, 2025
Real-world experience with cladribine in the two years since treatment start: A systematic review and meta-analysisAngela Albanese, Irene Schiavetti, Maria Pia Sormani
Multiple Sclerosis and Related Disorders|June 6, 2025
De-escalation of disease modifying therapies: A retrospective, observational single center studyCarolyn Goldschmidt, Jordan Glassman, Brandon Ly, et al.
Pageof 506